Journal of Clinical Oncology 2021

Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

Mascarenhas, et al.

[facetwp facet="publication_load_more"]